SCHEMBL31569633

SCHEMBL31569633

Cn1c(CO)nc2cc(Br)ccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
MAPK1 P28482 4/20 0.49
ALDH1A1 P00352 4/20 0.49
TP53 P04637 4/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GFER P55789 1/20 0.44
RHEB Q15382 1/20 0.44
USP2 O75604 1/20 0.42
HPGD P15428 2/20 0.42
LMNA P02545 2/20 0.41
THRB P10828 1/20 0.41
STAT3 P40763 1/20 0.41
MCL1 Q07820 1/20 0.41
HDAC6 Q9UBN7 6/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4777935 0.87 MAPT (0.45) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL30698370 0.87 MAPT (0.45) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL31569891 0.83 RAB9A (0.52) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL1972515 0.83 ALDH1A1 (0.40) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL13313014 0.81 KDM4E (0.57) MAPTALDH1A1TP53NPC1RAB9A
SCHEMBL2014360 0.81 PPARG (0.45) MAPK1ALDH1A1TP53TSHRMEN1
SCHEMBL3988029 0.80 KMT2A (0.55) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL19527344 0.80 MAPT (0.46) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL5074885 0.78 HDAC1 (0.47) MAPTMAPK1ALDH1A1TP53NPC1
SCHEMBL6247270 0.78 MAPK1 (0.50) MAPK1ALDH1A1TP53TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) 2026-01-15 US disclosed
WO-2025101588-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2025-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015321-A1 CHEMICAL COMPOUNDS AND USES THEREOF WRN, MSH2, MSH6 MAPT 4063/4885MAPK1 1628/4885ALDH1A1 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.